SCM Lifescience Co., Ltd.
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Long-term Safety Follow-up Study of SCM-AGH in Patients Who Completed SCM-APT2001 Study
- Conditions
- Pancreatitis, Acute
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- SCM Lifescience Co., LTD.
- Target Recruit Count
- 42
- Registration Number
- NCT05955235
- Locations
- 🇰🇷
Soonchunhyang University Hosptial Bucheon, Bucheon, Gyenggi-do, Korea, Republic of
🇰🇷Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of
🇰🇷Dongguk University Ilsan Hospital, Goyang-si, Korea, Republic of
Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis
- Conditions
- Pancreatitis, Acute
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- SCM Lifescience Co., LTD.
- Target Recruit Count
- 36
- Registration Number
- NCT04189419
- Locations
- 🇰🇷
Soonchunhyang University Hosptial Bucheon, Bucheon, Gyenggi-do, Korea, Republic of
🇰🇷Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of
🇰🇷Dongguk University Ilsan Hospital, Goyang-si, Korea, Republic of
Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease
- Conditions
- Chronic Graft-versus-host-disease
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- SCM Lifescience Co., LTD.
- Target Recruit Count
- 84
- Registration Number
- NCT04189432
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Korea, Republic of
🇰🇷Pusan National University Hospital, Busan, Korea, Republic of
Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical Trials
- Conditions
- Dermatitis, Atopic
- First Posted Date
- 2019-12-04
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- SCM Lifescience Co., LTD.
- Target Recruit Count
- 92
- Registration Number
- NCT04185584
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis
- Conditions
- Dermatitis, Atopic
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- SCM Lifescience Co., LTD.
- Target Recruit Count
- 92
- Registration Number
- NCT04179760
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of